BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26772441)

  • 21. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.
    Adams MJ; Lipsitz SR; Colan SD; Tarbell NJ; Treves ST; Diller L; Greenbaum N; Mauch P; Lipshultz SE
    J Clin Oncol; 2004 Aug; 22(15):3139-48. PubMed ID: 15284266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of valvular heart disease after treatment for Hodgkin lymphoma.
    Cutter DJ; Schaapveld M; Darby SC; Hauptmann M; van Nimwegen FA; Krol AD; Janus CP; van Leeuwen FE; Aleman BM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25713164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.
    Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM
    J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
    Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
    J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin's Lymphoma Survivors.
    Abou-Antoun T; Mikhael R; Massoud M; Chahine G; Saad A
    Asian Pac J Cancer Prev; 2016; 17(2):749-54. PubMed ID: 26925674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term complications in Hodgkin's lymphoma survivors.
    Kilickap S; Barista I; Ulger S; Celik I; Selek U; Güllü I; Yildiz F; Kars A; Ozisik Y; Tekuzman G
    Tumori; 2012; 98(5):601-6. PubMed ID: 23235755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation: evidence of cardiac autonomic dysfunction and impact on outcomes.
    Groarke JD; Tanguturi VK; Hainer J; Klein J; Moslehi JJ; Ng A; Forman DE; Di Carli MF; Nohria A
    J Am Coll Cardiol; 2015 Feb; 65(6):573-83. PubMed ID: 25677317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
    Schellong G; Riepenhausen M; Bruch C; Kotthoff S; Vogt J; Bölling T; Dieckmann K; Pötter R; Heinecke A; Brämswig J; Dörffel W
    Pediatr Blood Cancer; 2010 Dec; 55(6):1145-52. PubMed ID: 20734400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.
    van der Kaaij MA; Heutte N; Meijnders P; Abeilard-Lemoisson E; Spina M; Moser EC; Allgeier A; Meulemans B; Simons AH; Lugtenburg PJ; Aleman BM; Noordijk EM; Fermé C; Thomas J; Stamatoullas A; Fruchart C; Brice P; Gaillard I; Bologna S; Ong F; Eghbali H; Doorduijn JK; Morschhauser F; Sebban C; Roesink JM; Bouteloup M; Van Hoof A; Raemaekers JM; Henry-Amar M; Kluin-Nelemans HC
    J Clin Oncol; 2012 Jan; 30(3):291-9. PubMed ID: 22184372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma.
    Cella L; Conson M; Caterino M; De Rosa N; Liuzzi R; Picardi M; Grimaldi F; Solla R; Farella A; Salvatore M; Pacelli R
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1802-8. PubMed ID: 21514076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
    Boekel NB; Schaapveld M; Gietema JA; Russell NS; Poortmans P; Theuws JC; Schinagl DA; Rietveld DH; Versteegh MI; Visser O; Rutgers EJ; Aleman BM; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1061-72. PubMed ID: 27026313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue Doppler evaluation of systolic and diastolic cardiac functions in long-term survivors of Hodgkin lymphoma.
    Alehan D; Sahin M; Varan A; Yıldırım I; Küpeli S; Büyükpamukçu M
    Pediatr Blood Cancer; 2012 Feb; 58(2):250-5. PubMed ID: 21850678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
    Hancock SL; Donaldson SS; Hoppe RT
    J Clin Oncol; 1993 Jul; 11(7):1208-15. PubMed ID: 8315419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High risk of symptomatic cardiac events in childhood cancer survivors.
    van der Pal HJ; van Dalen EC; van Delden E; van Dijk IW; Kok WE; Geskus RB; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC
    J Clin Oncol; 2012 May; 30(13):1429-37. PubMed ID: 22473161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.
    Maraldo MV; Giusti F; Vogelius IR; Lundemann M; van der Kaaij MA; Ramadan S; Meulemans B; Henry-Amar M; Aleman BM; Raemaekers J; Meijnders P; Moser EC; Kluin-Nelemans HC; Feugier P; Casasnovas O; Fortpied C; Specht L;
    Lancet Haematol; 2015 Nov; 2(11):e492-502. PubMed ID: 26686259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
    Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study.
    Lund MB; Ihlen H; Voss BM; Abrahamsen AF; Nome O; Kongerud J; Stugaard M; Forfang K
    Heart; 1996 Jun; 75(6):591-5. PubMed ID: 8697163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
    Eroglu C; Kaynar L; Orhan O; Keklik M; Sahin C; Yildiz OG; Mentes S; Kurnaz F; Aslan D; Sivgin S; Soyuer S; Eser B; Cetin M; Unal A
    Am J Clin Oncol; 2015 Feb; 38(1):68-73. PubMed ID: 23563207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.